Inhibiting AKT/mTOR signaling by LY294002 was also found to further reduce the viability of IATL-treated CRC cells, suggesting that inhibition of AKT/mTOR signaling is in involved in IATL-mediated cell death. Here, AKT1 is linked to colorectal carcinoma.